Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4/A
Annovis Bio, Inc.
22 Nov 23
4
Annovis Bio, Inc.
21 Nov 23
4
Annovis Bio, Inc.
11 Apr 23
4
Annovis Bio, Inc.
20 Jan 23
4
Annovis Bio, Inc.
5 Jan 22
4
Annovis Bio, Inc.
9 Jul 21
3
Northern Genesis Acquisition Corp. III
24 Mar 21
3
Northern Genesis Acquisition Corp. II
13 Jan 21
4
Onconova Therapeutics, Inc.
31 Aug 20
3
Northern Genesis Acquisition Corp.
17 Aug 20
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Nov 23 | Hoffman Michael B | Common Stock | Grant | Acquire A | Yes | No | 6.1 | 163,880 | 999.67 k | 223,357 |
20 Nov 23 | Hoffman Michael B | Common Stock | Grant | Acquire A | Yes | No | 6.07 | 164,745 | 1.00 mm | 224,222 |
7 Apr 23 | Hoffman Michael B | Common Stock | Grant | Acquire A | Yes | No | 12.61 | 59,477 | 750.00 k | 59,477 |
18 Jan 23 | Hoffman Michael B | Stock Option Common Stock | Grant | Acquire A | No | No | 13.17 | 6,820 | 89.82 k | 6,820 |